WHO: Preliminary evidence no human-to-human transmission

In a January 14, 2020 tweet the WHO state the "[p]reliminary investigations conducted by the Chinese authorities have found no clear evidence of human-to-human transmission" of the novel coronavirus (2019-nCoV) identified in Wuhan China.  Six days later they "found" the evidence. [1]

Transmission phenomenon experienced in the unvaccinated

In May 2021 a new phenomenon occurred in unvaccinated women who spent time around the COVID-19 vaccinated, and afterwards experienced unusual bleeding symptoms, including very young children. [2] Pfizer clinical trial documented warned about “occupational exposure“, [1] and it appears that the US research institutes were aware of the potential for "shedding" since 2015. As these vaccines are brand new technology, there are still many unknowns that need investigating.

FDA issues first COVID-19 vaccine EUA for Pfizer-BioNTech with no data on “preventing transmission”

On December 11, 2020, the US Food and Drug Administration (FDA) granted the first Emergency Use Authorisation (EUA) for a brand new technology product, the Pfizer-BioNTech COVID-19 mRNA vaccine, just 9 months after phase I trials began, and after only 108 days of regulatory safety review. In their press release they stated: "The FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria for issuance of an EUA".  The FDA stated the vaccine "may be effective in preventing COVID-19", then state it is 95% effective in "preventing" COVID-19, that 95% is based on "a 2 month study of a couple hundred people.  That's it!". [3] The day before, on December 10, 2020, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to assess the Pfizer-BioNTech COVID-19 Vaccine and prepare a Briefing Document for the FDA. [6] The FDA stated "[t]he vaccine was 95% effective in preventing COVID-19 disease among these clinical trial participants with eight COVID-19 cases in the vaccine group and 162 in the placebo group."  8 plus 162 equals 170 trial participants was all that were used to determined the relative risk of "95% effective", where as the absolute risk (of all 36,523 trial participants)..> READ MORE

Asymptomatic transmission mode of infection is pushed

As the testing statistics begin to "show" that more people have recovered from COVID-19 infection, and the case fatality rate (CFR), which is inline with a bad flu season, the authorities keep pushing testing [PCR at 40-45 cycles] and now assume that asymptomatic spread is a mode of infection [@25min]. Yet previous information from the CDC and the China Report suggests that non-symptomatic people are “not thought to be the main way the virus spreads.”

China/WHO: Human to Human transmission confirmed

On January 20, 2020 it is reported that scientists in China confirm human-to-human transmission of the new novel coronavirus, showing it is "contagious". The WHO believe this is limited to “between close contacts”, as healthcare worker caring for patients with 2019-nCoV become infected. [1] Though intelligence from a leaked Five Eyes report suggests China was aware there was “evidence of human-human transmission from early December,” yet Chinese authorities denied such transmission “until January 20.” Officials in Taiwan had sounded the alarm about people spreading the virus to each other as early as December 31, 2019 and experts in Hong Kong did the same on January 4, 2020. [1] WHO state “animal-to-human infection still appeared to be the main source of the outbreak”. Global labs have begun work on “diagnostic tests” and started “work on a vaccine”. [At the same time President Trump is being impeached]

VPD Global Immunization goals now include eradicate, eliminate or control

May 15, 2024, under the Global Immunization Strategic Framework (GISF) (2021-2030) and part of WHO IA2030 the CDC launch a Global Immunization page for Vaccine-Preventable Diseases (VPD) which now has 3 distinct goals for "immunization systems and vaccination activities worldwide": eradicate, eliminate or control! Eradication is defined as the worldwide absence of a specific disease-causing agent in nature. Elimination of VPD transmission in a defined geographic area but vaccination must continue to prevent reemergence or Eliminating VPD because its a " public health problem" requiring vaccination (tetanus which is not infectious is on the list in the context of pregnancy!) Control of VPD  to reduce "disease and death to low levels locally"! Advance Development for diseases that don't currently have a vaccine! [2] The moment a vaccine is registered for a new disease we suddenly have a new vaccine-preventable disease - which takes potential lives could be saved numbers even higher!

The Global Polio Eradication Initiative (GPEI) begins

On May 13, 1988 at the 41st World Health Assembly the global polio eradication goal was set (resolution WHA41.28 [9]), marking the beginning of the Global Polio Eradication Initiative (GPEI).   At the time "over 35,000 cases" of polio were reported to the WHO. [1, 2]  In October 2023 the WHO claim that 1988 polio case number was 350,000 cases! "Until the 1950s, polio crippled thousands of children every year in industrialized countries." The Salk Inactivated Polio Virus (IPV) vaccine was released in 1955 (along with polio outbreaks and SV40 contamination) followed by Sabin's Oral Polio Virus (OPV) vaccine in 1963, following which WHO declare "polio was brought under control, and practically eliminated as a public health problem in industrialized countries". [8] Polio wasn't recognised in developing countries until 'lameness surveys' were conducted during the 1970s, following which national immunization with OPV began under the WHO's EPI program. [8] Polio was technically called Paralytic poliomyelitis, said to be "irreversible".  In April 1999 the WHO redefined cases as Acute Flaccid Paralysis (AFP) [6, 7] In 1997 the number of reported polio cases fell to 5,160, an almost 90% decrease [1, 2] In 1997 philanthropist Mr. R.E. (Ted) Turner made a gift of..> READ MORE

WHO declared smallpox eradicated

On May 8, 1980, the 33rd World Health Assembly, the World Health Organization (WHO) officials declared smallpox eradicated (WHA33.3) with the statement 'the world and all its peoples have won freedom from smallpox"..."Such an achievement is unprecedented in the history of public health." [1, 3, 4] The Global Commission for the Certification of Smallpox Eradication, which began in May 1978 and was led by Australia's Frank Fenner, submitted their final report in December 1979.  The report contained two conclusions: "that smallpox eradication has been achieved throughout the world; and, second, that there is no evidence that smallpox will return as an endemic disease". [5] The acceptance, as public health policy, of a planned programme designed to eradicate a disease over a large geographical area was a new development.  The global programme on smallpox eradication was initiated by the WHO in 1958 (WHA11.54). In 1966, the 19th WHA requested that the director general of WHO launch a global programme to eradicate smallpox, from 1967 the international cooperation "intensified". [5, 6, 7] Dryvax, a smallpox vaccine, originally licensed in 1944 to Wyeth Laboratories, Inc. was used in mass vaccination campaigns. [2] "Before 1967, the smallpox eradication strategy relied on mass vaccination. However,..> READ MORE

WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) is created

In September 29, 2021 the WHO established the Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC), as an "independent" group, yet the Chair and Vice-Chair are Influenza specialists from Australia (Peter Doherty Institute) and USA (CDC) respectively, who already "collaborate" with the WHO.  There are other members. [1] The purpose of the group is to assesses the impact of SARS-CoV-2 Variants of Concern (VOC) on the current COVID-19 vaccines and determine whether changes to vaccine antigen composition is needed for the upcoming seasonal COVID-19 vaccine - just as is done for influenza vaccines because rapidly mutating viruses always posses the capacity for immune escape! The intent is to achieve "minimally acceptable" levels of "protection of persons at at high ongoing risk of COVID-19 such as healthcare workers and for reactive use in outbreak settings with rapid onset of immunity." [2, 3, 4]  WHO has the entire system set up for annual COVID-19 vaccination - from virus to vaccine to implementation - into the mRNA Platform. On January 11, 2022 the first of many reports was released by TAG-CO-VAC, called "for the development of COVID-19 vaccines that have high impact on prevention of infection and transmission, in addition to protection against..> READ MORE